NCT05236387 2024-02-09
Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection
Johns Hopkins University
Terminated
Clinical Trials
8 trialsNCT04096716 2023-12-21
Mapping Draining Lymph Nodes in CNS Malignancies
Washington University School of Medicine
Phase 1 Terminated
NCT04663126 2023-12-13
Tilmanocept
University of Lausanne Hospitals
Phase EARLY_PHASE1 Terminated
NCT04511026 2023-10-11
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
Stanford University
Phase 2 Terminated
NCT03029988 2020-09-10
An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Navidea Biopharmaceuticals
Phase 1 Terminated
NCT02509585 2019-02-11
A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection
Cardinal Health 414, LLC
Phase 2 Terminated
NCT02589366 2018-10-15
Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
University of California, San Diego
Phase 1 Terminated
NCT00911326 2014-08-08
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Navidea Biopharmaceuticals
Phase 3 Terminated